MKS Instruments Reports Fourth Quarter and Full Year 2017 Financial Results
- 2017 was a record year in revenue and GAAP and Non-GAAP EPS
· Annual revenue increased 30% compared to pro-forma 2016 to a record$1.9 billion
· Annual semiconductor revenue increased 45% on a pro-forma basis to a record$1.1 billion
· Annual revenue in advanced markets increased 14% on a pro-forma basis to a record$820 million
· Light and Motion set new quarterly and annual revenue records and in Q4'17 exceeded$200 million in revenue for the first time
- Our 2018 January Operating Model shows a 33% increase in Non-GAAP EPS compared to the
October 2017 Operating Model
GAAP Financial Results1 | |||||||
Q4 | Full Year | ||||||
2017 | 2016 | 2017 | 2016 | ||||
Net revenues ($ millions) | |||||||
Operating margin | 23.4% | 15.4% | 21.2% | 12.1% | |||
Net income ($ millions) | |||||||
Diluted EPS | |||||||
Non-GAAP Financial Results1 | |||||||
Q4 | Full Year | ||||||
2017 | 2016 | 2017 | 2016 | ||||
Net revenues ($ millions) | |||||||
Operating margin | 25.9% | 20.6% | 24.6% | 18.7% | |||
Net earnings ($ millions) | |||||||
Diluted EPS | |||||||
1 The full year 2016 results include the results of | |||||||
Fourth Quarter Financial Results
Sales were
Fourth quarter net income was
Non-GAAP net earnings, which exclude special charges and credits, were
Sales to semiconductor customers were
Sales in the Vacuum and Analysis segment, the historic MKS business, set a quarterly record of
Additional Financial Information
The Company had
Full Year Results
Sales were a record
Sales in the Vacuum and Analysis segment were
Sales in the Light and Motion segment were
"We are very pleased with our fourth quarter and full year 2017 results, which set new records for revenue and
profitability, in both of our segments," said
"The acquisition of
First Quarter 2018 Outlook
Based on current business levels, the Company expects that sales in the first quarter of 2018 may range from
The Company also published an updated operating model, which reflects an illustrative revenue level of
A conference call with management will be held on
About MKS Instruments
Use of Non-GAAP Financial Results
Non-GAAP amounts exclude amortization of acquired intangible assets, asset impairments, costs associated with completed and announced acquisitions, acquisition integration costs, restructuring charges, certain excess and obsolete inventory charges, fees and expenses related to re-pricing of the Company's term loan, amortization of debt issuance costs, net proceeds from an insurance policy, costs associated with the sale of a business, the tax effects of the 2017 Tax Cut and Jobs Act, the tax effect of legal entity restructurings, other discrete tax benefits and charges, and the related tax effect of these adjustments. These non-GAAP measures are not in accordance with generally accepted accounting principles in
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
This
release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the future financial performance, business prospects and growth of MKS as well as expected synergies and cost savings from the acquisition of
Company Contact:
Senior Vice President, Chief Financial Officer and Treasurer
Telephone: 978.645.5578
Investor Relations Contacts:
Telephone: 212.871.3927
Email: monica@blueshirtgroup.com
Telephone:
212.331.8417
Email: lindsay@blueshirtgroup.com
Unaudited Consolidated Statements of Operations | |||||||||||||
(In thousands, except per share data) | |||||||||||||
Three Months Ended | |||||||||||||
2017 | 2016 | 2017 | |||||||||||
Net revenues: | |||||||||||||
Products | $ | 463,851 | $ | 359,765 | $ | 434,710 | |||||||
Services | 47,949 | 45,375 | 51,557 | ||||||||||
Total net revenues | 511,800 | 405,140 | 486,267 | ||||||||||
Cost of revenues: | |||||||||||||
Products | 242,008 | 194,716 | 225,174 | ||||||||||
Services | 31,466 | 27,016 | 33,098 | ||||||||||
Total cost of revenues | 273,474 | 221,732 | 258,272 | ||||||||||
Gross profit | 238,326 | 183,408 | 227,995 | ||||||||||
Research and development | 33,045 | 32,870 | 32,548 | ||||||||||
Selling, general and administrative | 72,510 | 67,626 | 71,839 | ||||||||||
Acquisition and integration costs | 634 | 2,089 | 2,466 | ||||||||||
Restructuring | 1,324 | 618 | 10 | ||||||||||
Asset impairment | - | 5,000 | - | ||||||||||
Amortization of intangible assets | 10,797 | 12,691 | 10,977 | ||||||||||
Income from operations | 120,016 | 62,514 | 110,155 | ||||||||||
Interest income | 1,125 | 702 | 873 | ||||||||||
Interest expense | 7,989 | 10,085 | 7,172 | ||||||||||
Other expense, net | 2,155 | 3,575 | 2,485 | ||||||||||
Income from operations before income taxes | 110,997 | 49,556 | 101,371 | ||||||||||
Provision for income taxes | 33,359 | 4,069 | 25,377 | ||||||||||
Net income | $ | 77,638 | $ | 45,487 | $ | 75,994 | |||||||
Net income per share: | |||||||||||||
Basic | $ | 1.43 | $ | 0.85 | $ | 1.40 | |||||||
Diluted | $ | 1.41 | $ | 0.83 | $ | 1.38 | |||||||
Cash dividends per common share | $ | 0.18 | $ | 0.17 | $ | 0.175 | |||||||
Weighted average shares outstanding: | |||||||||||||
Basic | 54,318 | 53,617 | 54,282 | ||||||||||
Diluted | 55,236 | 54,518 | 55,101 | ||||||||||
The following supplemental Non-GAAP earnings information is presented | |||||||||||||
to aid in understanding MKS' operating results: | |||||||||||||
Net income | $ | 77,638 | $ | 45,487 | $ | 75,994 | |||||||
Adjustments: | |||||||||||||
Acquisition and integration costs (Note 1) | 634 | 2,089 | 2,466 | ||||||||||
Fees and expenses relating to re-pricing of term loan (Note 2) | - | 526 | 492 | ||||||||||
Amortization of debt issuance costs (Note 3) | 3,983 | 2,430 | 2,314 | ||||||||||
Restructuring (Note 4) | 1,324 | 618 | 10 | ||||||||||
Asset impairment (Note 5) | - | 5,000 | - | ||||||||||
Amortization of intangible assets | 10,797 | 12,691 | 10,977 | ||||||||||
Windfall tax benefit on stock-based compensation (Note 6) | (658 | ) | - | (594 | ) | ||||||||
Withholding tax on dividends (Note 7) | - | 1,362 | - | ||||||||||
Tax benefit from a legal entity restructuring (Note 8) | - | (6,570 | ) | - | |||||||||
Deferred tax adjustment (Note 9) | (24,546 | ) | - | - | |||||||||
Transition tax on accumulated foreign earnings (Note 10) | 28,658 | - | - | ||||||||||
Tax adjustment related to the sale of a business (Note 11) | (12,131 | ) | - | - | |||||||||
Accrued tax on MKS subsidiary distribution (Note 12) | 14,000 | - | - | ||||||||||
Pro-forma tax adjustments | (5,083 | ) | (6,437 | ) | (5,789 | ) | |||||||
Non-GAAP net earnings | $ | 94,616 | $ | 57,196 | $ | 85,870 | |||||||
Non-GAAP net earnings per share | $ | 1.71 | $ | 1.05 | $ | 1.56 | |||||||
Weighted average shares outstanding | 55,236 | 54,518 | 55,101 | ||||||||||
Income from operations | $ | 120,016 | $ | 62,514 | $ | 110,155 | |||||||
Adjustments: | |||||||||||||
Acquisition and integration costs (Note 1) | 634 | 2,089 | 2,466 | ||||||||||
Fees and expenses relating to re-pricing of term loan (Note 2) | - | 526 | 492 | ||||||||||
Restructuring (Note 4) | 1,324 | 618 | 10 | ||||||||||
Asset impairment (Note 5) | - | 5,000 | - | ||||||||||
Amortization of intangible assets | 10,797 | 12,691 | 10,977 | ||||||||||
Non-GAAP income from operations | $ | 132,771 | $ | 83,438 | $ | 124,100 | |||||||
Non-GAAP operating margin percentage | 25.9 | % | 20.6 | % | 25.5 | % | |||||||
Interest expense | $ | 7,989 | $ | 10,085 | $ | 7,172 | |||||||
Amortization of debt issuance costs (Note 3) | 3,983 | 2,430 | 2,314 | ||||||||||
Non-GAAP interest expense | $ | 4,006 | $ | 7,655 | $ | 4,858 | |||||||
Net income | $ | 77,638 | $ | 45,487 | $ | 75,994 | |||||||
Interest expense, net | 6,864 | 9,383 | 6,299 | ||||||||||
Provision for income taxes | 33,359 | 4,069 | 25,377 | ||||||||||
Depreciation | 9,208 | 9,478 | 9,153 | ||||||||||
Amortization | 10,797 | 12,691 | 10,977 | ||||||||||
EBITDA | $ | 137,866 | $ | 81,108 | $ | 127,800 | |||||||
Stock-based compensation | 4,544 | 5,402 | 4,846 | ||||||||||
Acquisition and integration costs (Note 1) | 634 | 2,089 | 2,466 | ||||||||||
Fees and expenses relating to re-pricing of term loan (Note 2) | - | 526 | 492 | ||||||||||
Restructuring (Note 4) | 1,324 | 618 | 10 | ||||||||||
Asset impairment (Note 5) | - | 5,000 | - | ||||||||||
Other adjustments | 839 | 817 | 836 | ||||||||||
Adjusted EBITDA | $ | 145,207 | $ | 95,560 | $ | 136,450 | |||||||
Note 1: We recorded acquisition and integration costs related to the | |||||||||||||
Note 2: We recorded fees and expenses related to the re-pricing of our Term Loan Credit Agreement during the three month periods ended | |||||||||||||
Note 3: We recorded additional interest expense related to the amortization of debt issuance costs affiliated with our Term Loan Credit Agreement and ABL Facility. | |||||||||||||
Note 4: We recorded restructuring costs, primarily related to the consolidation of two manufacturing plants during the three months ended | |||||||||||||
Note 5: We recorded an asset impairment charge related to a minority interest investment in a privately held company during the three months ended | |||||||||||||
Note 6: We recorded windfall tax benefits on the vesting of stock-based compensation during the three months ended | |||||||||||||
Note 7: We recorded withholding tax on intercompany dividends during the three months ended | |||||||||||||
Note 8: We recorded a tax benefit related to a legal entity restructuring during the three months ended | |||||||||||||
Note 9: We recorded a deferred tax adjustment, which also includes the reversal of a tax accrual on a French dividend, related to | |||||||||||||
Note 10*: We recorded a transition tax on accumulated foreign earnings related to the 2017 Tax Cut and Jobs Act during the three months ended | |||||||||||||
Note 11*: We recorded a tax adjustment resulting from the 2017 Tax Cut and Jobs Act, related to the sale of our Data Analytics Solutions business during the three months ended | |||||||||||||
Note 12*: We recorded an accrual for tax expense on a potential distribution to a subsidiary, related to the 2017 Tax Cut and Jobs Act during the three months ended | |||||||||||||
*The computation of the one-time tax on our offshore earnings pursuant to the 2017 Tax Cut and Jobs Act (the "Tax Act") as well as our net deferred tax liability is based on our current understanding and assumptions regarding the impact of the Tax Act, and may change as additional clarification and implementation guidance is issued and as the interpretation of the Tax Act evolves over time. | |||||||||||||
Unaudited Consolidated Statements of Operations | |||||||||
(In thousands, except per share data) | |||||||||
Twelve Months Ended | |||||||||
2017 | 2016 | ||||||||
Net revenues: | |||||||||
Products | $ | 1,723,433 | $ | 1,134,013 | |||||
Services | 192,544 | 161,329 | |||||||
Total net revenues | 1,915,977 | 1,295,342 | |||||||
Cost of revenues: | |||||||||
Products | 901,546 | 627,850 | |||||||
Services | 122,980 | 101,873 | |||||||
Total cost of revenues | 1,024,526 | 729,723 | |||||||
Gross profit | 891,451 | 565,619 | |||||||
Research and development | 132,555 | 110,579 | |||||||
Selling, general and administrative | 290,548 | 229,171 | |||||||
Acquisition and integration costs | 5,332 | 27,279 | |||||||
Restructuring | 3,920 | 642 | |||||||
Asset impairment | 6,719 | 5,000 | |||||||
Amortization of intangible assets | 45,743 | 35,681 | |||||||
Income from operations | 406,634 | 157,267 | |||||||
Interest income | 3,021 | 2,560 | |||||||
Interest expense | 30,990 | 30,611 | |||||||
Gain on sale of business | 74,856 | - | |||||||
Other expense, net | 5,896 | 1,239 | |||||||
Income from operations before income taxes | 447,625 | 127,977 | |||||||
Provision for income taxes | 108,493 | 23,168 | |||||||
Net income | $ | 339,132 | $ | 104,809 | |||||
Net income per share: | |||||||||
Basic | $ | 6.26 | $ | 1.96 | |||||
Diluted | $ | 6.16 | $ | 1.94 | |||||
Cash dividends per common share | $ | 0.71 | $ | 0.68 | |||||
Weighted average shares outstanding: | |||||||||
Basic | 54,137 | 53,472 | |||||||
Diluted | 55,074 | 54,051 | |||||||
The following supplemental Non-GAAP earnings information is presented | |||||||||
to aid in understanding MKS' operating results: | |||||||||
Net income | $ | 339,132 | $ | 104,809 | |||||
Adjustments: | |||||||||
Acquisition and integration costs (Note 1) | 5,332 | 27,279 | |||||||
Acquisition inventory step-up (Note 2) | - | 15,090 | |||||||
Expenses related to sale of a business (Note 3) | 859 | - | |||||||
Excess and obsolete inventory charge (Note 4) | 1,160 | - | |||||||
Fees and expenses relating to re-pricing of term loan (Note 5) | 492 | 1,239 | |||||||
Amortization of debt issuance costs (Note 6) | 9,405 | 6,897 | |||||||
Restructuring (Note 7) | 3,920 | 642 | |||||||
Asset impairment (Note 8) | 6,719 | 5,000 | |||||||
Gain on sale of business (Note 9) | (74,856 | ) | - | ||||||
Net proceeds from an insurance policy (Note 10) | - | (1,323 | ) | ||||||
Amortization of intangible assets | 45,743 | 35,681 | |||||||
Taxes related to the sale of a business (Note 11) | 2,876 | - | |||||||
Windfall tax benefit on stock-based compensation (Note 12) | (11,071 | ) | - | ||||||
Withholding tax on dividends (Note 13) | - | 1,362 | |||||||
Tax benefit from a legal entity restructuring (Note 14) | - | (5,038 | ) | ||||||
Deferred tax adjustment (Note 15) | (24,546 | ) | - | ||||||
Transition tax on accumulated foreign earnings (Note 16) | 28,658 | - | |||||||
Accrued tax on MKS subsidiary distribution (Note 17) | 14,000 | - | |||||||
Pro-forma tax adjustments | (19,639 | ) | (27,617 | ) | |||||
Non-GAAP net earnings | $ | 328,184 | $ | 164,021 | |||||
Non-GAAP net earnings per share | $ | 5.96 | $ | 3.03 | |||||
Weighted average shares outstanding | 55,074 | 54,051 | |||||||
Income from operations | $ | 406,634 | $ | 157,267 | |||||
Adjustments: | |||||||||
Acquisition and integration costs (Note 1) | 5,332 | 27,279 | |||||||
Acquisition inventory step-up (Note 2) | - | 15,090 | |||||||
Expenses related to the sale of a business (Note 3) | 859 | - | |||||||
Excess and obsolete inventory charge (Note 4) | 1,160 | - | |||||||
Fees and expenses relating to re-pricing of term loan (Note 5) | 492 | 1,239 | |||||||
Restructuring (Note 7) | 3,920 | 642 | |||||||
Asset impairment (Note 8) | 6,719 | 5,000 | |||||||
Amortization of intangible assets | 45,743 | 35,681 | |||||||
Non-GAAP income from operations | $ | 470,859 | $ | 242,198 | |||||
Non-GAAP operating margin percentage | 24.6 | % | 18.7 | % | |||||
Gross profit | $ | 891,451 | $ | 565,619 | |||||
Acquisition inventory step-up (Note 2) | - | 15,090 | |||||||
Excess and obsolete inventory charge (Note 4) | 1,160 | - | |||||||
Non-GAAP gross profit | $ | 892,611 | $ | 580,709 | |||||
Non-GAAP gross profit percentage | 46.6 | % | 44.8 | % | |||||
Interest expense | $ | 30,990 | $ | 30,611 | |||||
Amortization of debt issuance costs (Note 6) | 9,405 | 6,897 | |||||||
Non-GAAP interest expense | $ | 21,585 | $ | 23,714 | |||||
Net income | $ | 339,132 | $ | 104,809 | |||||
Interest expense, net | 27,969 | 28,051 | |||||||
Provision for income taxes | 108,493 | 23,168 | |||||||
Depreciation | 36,813 | 30,245 | |||||||
Amortization | 45,743 | 35,681 | |||||||
EBITDA | $ | 558,150 | $ | 221,954 | |||||
Stock-based compensation | 24,378 | 25,228 | |||||||
Acquisition and integration costs (Note 1) | 5,332 | 27,279 | |||||||
Acquisition inventory step-up (Note 2) | - | 15,090 | |||||||
Expenses related to the sale of a business (Note 3) | 859 | - | |||||||
Excess and obsolete inventory charge (Note 4) | 1,160 | - | |||||||
Fees and expenses relating to re-pricing of term loan (Note 5) | 492 | 1,239 | |||||||
Restructuring (Note 7) | 3,920 | 642 | |||||||
Asset impairment (Note 8) | 6,719 | 5,000 | |||||||
Gain on sale of business (Note 9) | (74,856 | ) | - | ||||||
Net proceeds from an insurance policy (Note 10) | - | (1,323 | ) | ||||||
Other adjustments | 3,244 | 2,312 | |||||||
Adjusted EBITDA | $ | 529,398 | $ | 297,421 | |||||
Note 1: We recorded acquisition and integration costs related to the | |||||||||
Note 2: We recorded a charge in cost of sales related to the step-up of inventory to fair value as a result of the | |||||||||
Note 3: We recorded legal, consulting and compensation related expenses related to the sale of a business, during the twelve months ended | |||||||||
Note 4: We recorded excess and obsolete inventory charges in cost of sales related to the discontinuation of a product line in connection with the consolidation of two manufacturing plants during the twelve months ended
| |||||||||
Note 5: We recorded fees and expenses related to re-pricings of our Term Loan Credit Agreement. | |||||||||
Note 6: We recorded additional interest expense related to the amortization of debt issuance costs affiliated with our Term Loan Credit Agreement and ABL Facility. | |||||||||
Note 7: We recorded restructuring costs related to the consolidation of two manufacturing plants, a restructuring of one of our international facilities and the consolidation of sales offices during the twelve months ended | |||||||||
Note 8: We recorded an asset impairment charge, primarily related to the write-off of goodwill and intangible assets, in conjunction with the
consolidation of two manufacturing plants during the twelve months ended | |||||||||
Note 9: We recorded a gain on the sale of our Data Analytics Solutions business during the twelve months ended | |||||||||
Note 10: We recorded net proceeds from a Company owned life insurance policy during the twelve months ended | |||||||||
Note 11: We recorded taxes related to the sale of our Data Analytics Solutions business during the twelve months ended | |||||||||
Note 12: We recorded a windfall tax benefit on the vesting of stock-based compensation relating to the implementation of a
new accounting standard issued by the | |||||||||
Note 13: We recorded a withholding tax on intercompany dividends during the twelve months ended | |||||||||
Note 14: We recorded a tax benefit related to a legal entity restructuring during the
twelve months ended | |||||||||
Note 15*: We recorded a deferred tax adjustment, which also includes the reversal of a tax accrual on a French dividend, related to the 2017 Tax Cut and Jobs Act during the twelve months ended | |||||||||
Note 16*: We recorded a transition tax on accumulated foreign earnings related to the 2017 Tax Cut and Jobs Act during the twelve months
ended | |||||||||
Note 17*: We recorded an accrual for tax expense on a potential distribution to a subsidiary, related to the 2017 Tax Cut and Jobs Act during the twelve months ended | |||||||||
*The computation of the one-time tax on our offshore earnings pursuant to the 2017 Tax Cut and Jobs Act (the "Tax Act") as well as our net deferred tax liability is based
on our current understanding and assumptions regarding the impact of the Tax Act, and may change as additional clarification and implementation guidance is issued and as the interpretation of the Tax Act evolves over time. | |||||||||
Unaudited Consolidated Statements of Cash Flows | ||||||||||||
(In thousands, except per share data) | ||||||||||||
Three Months Ended | ||||||||||||
2017 | 2016 | 2017 | ||||||||||
Cash flows from operating activities: | ||||||||||||
Net income | $ | 77,638 | $ | 45,487 | $ | 75,994 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
Depreciation and amortization | 20,006 | 22,169 | 20,130 | |||||||||
Amortization of debt issuance costs and original issue discount | 4,314 | 2,812 | 2,643 | |||||||||
Stock-based compensation | 4,544 | 5,402 | 4,845 | |||||||||
Provision for excess and obsolete inventory | 4,864 | 4,994 | 4,347 | |||||||||
Provision for doubtful accounts | 175 | 943 | 139 | |||||||||
Deferred income taxes | (16,528 | ) | (29,255 | ) | (1,157 | ) | ||||||
Excess tax benefit from stock-based compensation | - | (790 | ) | - | ||||||||
Asset impairment | - | 5,000 | - | |||||||||
Other | (7 | ) | 131 | 36 | ||||||||
Changes in operating assets and liabilities | (14,220 | ) | (4,172 | ) | (8,014 | ) | ||||||
Net cash provided by operating activities | 80,786 | 52,721 | 98,963 | |||||||||
Cash flows from investing activities: | ||||||||||||
Purchases of investments | (30,545 | ) | (152,383 | ) | (129,430 | ) | ||||||
Sales of investments | 9,993 | 1,404 | 18,252 | |||||||||
Maturities of investments | 40,563 | 12,311 | 31,545 | |||||||||
Purchases of property, plant and equipment | (13,431 | ) | (7,164 | ) | (8,118 | ) | ||||||
Other | 66 | 232 | - | |||||||||
Net cash provided by (used in) investing activities | 6,646 | (145,600 | ) | (87,751 | ) | |||||||
Cash flows from financing activities: | ||||||||||||
Restricted cash | (177 | ) | 316 | 5,163 | ||||||||
Payments of short-term borrowings | (16,435 | ) | (3,453 | ) | (4,020 | ) | ||||||
Proceeds from short and long-term borrowings | 15,394 | 4,438 | 4,522 | |||||||||
Payments of long-term borrowings | (50,000 | ) | (41,570 | ) | (125,000 | ) | ||||||
Dividend payments | (9,775 | ) | (9,112 | ) | (9,500 | ) | ||||||
Excess tax benefit from stock-based compensation | - | 790 | - | |||||||||
Net proceeds related to employee stock awards | 2,504 | 1,186 | (1,306 | ) | ||||||||
Net cash used in financing activities | (58,489 | ) | (47,405 | ) | (130,141 | ) | ||||||
Effect of exchange rate changes on cash and cash equivalents | (1,152 | ) | 2,033 | 2,076 | ||||||||
Increase (decrease) in cash and cash equivalents | 27,791 | (138,251 | ) | (116,853 | ) | |||||||
Cash and cash equivalents at beginning of period | 305,977 | 366,874 | 422,830 | |||||||||
Cash and cash equivalents at end of period | $ | 333,768 | $ | 228,623 | $ | 305,977 | ||||||
Unaudited Consolidated Statements of Cash Flows | ||||||||
(In thousands, except per share data) | ||||||||
Twelve Months Ended | ||||||||
2017 | 2016 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 339,132 | $ | 104,809 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 82,556 | 65,926 | ||||||
Amortization of inventory step-up adjustment to fair value | - | 15,090 | ||||||
Amortization of debt issuance costs and original issue discount | 10,699 | 9,265 | ||||||
Stock-based compensation | 24,378 | 25,228 | ||||||
Provision for excess and obsolete inventory | 20,213 | 16,039 | ||||||
Provision for doubtful accounts | 825 | 1,109 | ||||||
Deferred income taxes | (9,886 | ) | (38,822 | ) | ||||
Excess tax benefit from stock-based compensation | - | (1,468 | ) | |||||
Asset impairment | 6,719 | 5,000 | ||||||
Gain on sale of business | (74,856 | ) | - | |||||
Other | 824 | 256 | ||||||
Changes in operating assets and liabilities | (45,382 | ) | (22,334 | ) | ||||
Net cash provided by operating activities | 355,222 | 180,098 | ||||||
Cash flows from investing activities: | ||||||||
Net proceeds from the sale of a business | 72,509 | - | ||||||
Acquisition of business, net of cash acquired | - | (939,591 | ) | |||||
Purchases of investments | (229,557 | ) | (268,458 | ) | ||||
Sales of investments | 53,564 | 338,996 | ||||||
Maturities of investments | 157,342 | 160,917 | ||||||
Purchases of property, plant and equipment | (31,287 | ) | (19,123 | ) | ||||
Other | 66 | 273 | ||||||
Net cash provided by (used in) investing activities | 22,637 | (726,986 | ) | |||||
Cash flows from financing activities: | ||||||||
Restricted cash | 4,835 | (5,860 | ) | |||||
Payments of short-term borrowings | (29,711 | ) | (11,742 | ) | ||||
Proceeds from short-term borrowings | 28,360 | 18,964 | ||||||
Payments of long-term borrowings | (228,141 | ) | (153,395 | ) | ||||
Proceeds from long-term borrowings | 191 | 744,653 | ||||||
Repurchases of common stock | - | (1,545 | ) | |||||
Dividend payments | (38,178 | ) | (36,361 | ) | ||||
Excess tax benefit from stock-based compensation | - | 1,468 | ||||||
Net proceeds related to employee stock awards | (12,215 | ) | (1,922 | ) | ||||
Net cash (used in) provided by financing activities | (274,859 | ) | 554,260 | |||||
Effect of exchange rate changes on cash and cash equivalents | 2,145 | (6,323 | ) | |||||
Increase in cash and cash equivalents | 105,145 | 1,049 | ||||||
Cash and cash equivalents at beginning of year | 228,623 | 227,574 | ||||||
Cash and cash equivalents at end of year | $ | 333,768 | $ | 228,623 | ||||
Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate | |||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Three Months Ended | Three Months Ended | ||||||||||||||||||||||
Income Before | Provision (benefit) | Effective | Income Before | Provision (benefit) | Effective | ||||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | Income Taxes | for Income Taxes | Tax Rate | ||||||||||||||||||
GAAP | $ | 110,997 | $ | 33,359 | 30.1 | % | $ | 101,371 | $ | 25,377 | 25.0 | % | |||||||||||
Adjustments: | |||||||||||||||||||||||
Acquisition and integration costs (Note 1) | 634 | - | 2,466 | - | |||||||||||||||||||
Fees and expenses relating to re-pricing of term loan (Note 5) | - | - | 492 | - | |||||||||||||||||||
Amortization of debt issuance costs (Note 6) | 3,983 | - | 2,314 | - | |||||||||||||||||||
Restructuring (Note 7) | 1,324 | - | 10 | - | |||||||||||||||||||
Amortization of intangible assets | 10,797 | - | 10,977 | - | |||||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 10) | - | 658 | - | 594 | |||||||||||||||||||
Deferred tax adjustment (Note 15) | - | 24,546 | - | - | |||||||||||||||||||
Transition tax on accumulated foreign earnings (Note 16) | - | (28,658 | ) | - | - | ||||||||||||||||||
Accrued tax on MKS subsidiary distribution (Note 17) | - | (14,000 | ) | - | - | ||||||||||||||||||
Tax adjustment related to the sale of a business (Note 11) | - | 12,131 | - | - | |||||||||||||||||||
Tax effect of pro-forma adjustments | - | 5,083 | - | 5,789 | |||||||||||||||||||
Non-GAAP | $ | 127,735 | $ | 33,119 | 25.9 | % | $ | 117,630 | $ | 31,760 | 27.0 | % | |||||||||||
Three Months Ended | |||||||||||||||||||||||
Income Before | Provision (benefit) | Effective | |||||||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | |||||||||||||||||||||
GAAP | $ | 49,556 | $ | 4,069 | 8.2 | % | |||||||||||||||||
Adjustments: | |||||||||||||||||||||||
Acquisition and integration costs (Note 1) | 2,089 | - | |||||||||||||||||||||
Fees and expenses relating to re-pricing of term loan (Note 5) | 526 | - | |||||||||||||||||||||
Amortization of debt issuance costs (Note 6) | 2,430 | - | |||||||||||||||||||||
Restructuring (Note 7) | 618 | - | |||||||||||||||||||||
Asset impairment (Note 8) | 5,000 | - | |||||||||||||||||||||
Amortization of intangible assets | 12,691 | - | |||||||||||||||||||||
Taxes related to a legal entity restructuring (Note 13) | - | 6,570 | |||||||||||||||||||||
Withholding tax on dividends (Note 14) | - | (1,362 | ) | ||||||||||||||||||||
Tax effect of pro-forma adjustments | - | 6,437 | |||||||||||||||||||||
Non-GAAP | $ | 72,910 | $ | 15,714 | 21.6 | % | |||||||||||||||||
Twelve Months Ended | Twelve Months Ended | ||||||||||||||||||||||
Income Before | Provision (benefit) | Effective | Income Before | Provision (benefit) | Effective | ||||||||||||||||||
Income Taxes | for Income Taxes | Tax Rate | Income Taxes | for Income Taxes | Tax Rate | ||||||||||||||||||
GAAP | $ | 447,625 | $ | 108,493 | 24.2 | % | $ | 127,977 | $ | 23,168 | 18.1 | % | |||||||||||
Adjustments: | |||||||||||||||||||||||
Acquisition and integration costs (Note 1) | 5,332 | - | 27,279 | - | |||||||||||||||||||
Acquisition inventory step-up (Note 2) | - | - | 15,090 | - | |||||||||||||||||||
Expenses related to the sale of a business (Note 3) | 859 | - | - | - | |||||||||||||||||||
Excess and obsolete inventory charge (Note 4) | 1,160 | - | - | - | |||||||||||||||||||
Fees and expenses relating to re-pricing of term loan (Note 5) | 492 | - | 1,239 | - | |||||||||||||||||||
Amortization of debt issuance costs (Note 6) | 9,405 | - | 6,897 | - | |||||||||||||||||||
Restructuring (Note 7) | 3,920 | - | 642 | - | |||||||||||||||||||
Asset impairment (Note 8) | 6,719 | - | 5,000 | - | |||||||||||||||||||
Gain on sale of business (Note 9) | (74,856 | ) | - | - | - | ||||||||||||||||||
Amortization of intangible assets | 45,743 | - | 35,681 | - | |||||||||||||||||||
Windfall tax benefit on stock-based compensation (Note 10) | - | 11,071 | - | - | |||||||||||||||||||
Taxes related to the sale of a business (Note 11) | - | (2,876 | ) | - | - | ||||||||||||||||||
Net proceeds from an insurance policy (Note 12) | - | - | (1,323 | ) | - | ||||||||||||||||||
Taxes related to a legal entity restructuring (Note 13) | - | - | - | 5,038 | |||||||||||||||||||
Withholding tax on dividends (Note 14) | - | - | - | (1,362 | ) | ||||||||||||||||||
Deferred tax adjustment (Note 15) | - | 24,546 | - | - | |||||||||||||||||||
Transition tax on accumulated foreign earnings (Note 16) | - | (28,658 | ) | - | - | ||||||||||||||||||
Accrued tax on MKS subsidiary distribution (Note 17) | - | (14,000 | ) | - | - | ||||||||||||||||||
Tax effect of pro-forma adjustments | - | 19,639 | - | 27,617 | |||||||||||||||||||
Non-GAAP | $ | 446,399 | $ | 118,215 | 26.5 | % | $ | 218,482 | $ | 54,461 | 24.9 | % | |||||||||||
Note 1: Acquisition and integration costs related to the | |||||||||||||||||||||||
Note 2: We recorded a charge in cost of sales related to the step-up of inventory to fair value as a result of the | |||||||||||||||||||||||
Note 3: We recorded expenses related to the sale of a business, during the twelve months ended
| |||||||||||||||||||||||
Note 4: We recorded excess and obsolete inventory charges in cost of sales related to the discontinuation of a product line in connection with the consolidation of two manufacturing plants, during the twelve months ended | |||||||||||||||||||||||
Note 5: We recorded fees and expenses related to the re-pricing of our Term Loan Credit Agreement, during the three months ended | |||||||||||||||||||||||
Note 6: Amortization of debt issuance costs are affiliated with our Term Loan Credit Agreement and ABL Facility. | |||||||||||||||||||||||
Note 7: We recorded restructuring costs primarily related to the consolidation of two manufacturing plants and costs related to a restructuring of one of our international facilities and the consolidation of sales offices during the three and twelve months ended | |||||||||||||||||||||||
Note 8: We recorded an asset impairment charge, during the twelve months ended | |||||||||||||||||||||||
Note 9: We recorded a gain on the sale of our Data Analytics Solutions business during the twelve months ended | |||||||||||||||||||||||
Note 10: We recorded a windfall tax benefit on the vesting of stock-based compensation, relating to the implementation of a new accounting standard issued by the | |||||||||||||||||||||||
Note 11: We recorded taxes related to the sale of our Data Analytics Solutions business during the twelve months ended | |||||||||||||||||||||||
Note 12: We recorded net proceeds from a Company owned life insurance policy during the twelve months ended | |||||||||||||||||||||||
Note 13: We recorded a tax expense related to a legal entity restructuring during the twelve months ended | |||||||||||||||||||||||
Note 14: We recorded withholding tax on intercompany dividends during the three and twelve months ended | |||||||||||||||||||||||
Note 15*: We recorded a deferred tax adjustment, which also includes the reversal of a tax accrual on a French dividend, related to the 2017 Tax Cut and Jobs Act during the three and twelve months ended | |||||||||||||||||||||||
Note 16*: We recorded a transition tax on accumulated foreign earnings related to the 2017 Tax Cut and Jobs Act during the three and twelve months ended | |||||||||||||||||||||||
Note 17*: We recorded an accrual for tax expense on a potential distribution to a subsidiary, related to the 2017 Tax Cut and Jobs Act during the three and twelve months ended
| |||||||||||||||||||||||
*The computation of the one-time tax on our offshore earnings pursuant to the 2017 Tax Cut and Jobs Act (the "Tax Act") as well as our net deferred tax liability is based on our current understanding and assumptions regarding the impact of the Tax Act, and may change as additional clarification and implementation guidance is issued and as the interpretation of the Tax Act evolves over time. | |||||||||||||||||||||||
Reconciliation of Q1-18 Guidance - GAAP Net Income to Non-GAAP Net Earnings | |||||||||||||||||||||||
(In thousands, except per share data) | |||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||
Low Guidance | High Guidance | ||||||||||||||||||||||
$ Amount | $ Per Share | $ Amount | $ Per Share | ||||||||||||||||||||
GAAP net income | $ | 93,200 | $ | 1.68 | $ | 108,100 | $ | 1.95 | |||||||||||||||
Amortization | 11,000 | 0.20 | 11,000 | 0.20 | |||||||||||||||||||
Deferred financing costs | 900 | 0.02 | 900 | 0.02 | |||||||||||||||||||
Tax effect of adjustments (Note 1) | (2,200 | ) | (0.04 | ) | (2,300 | ) | (0.04 | ) | |||||||||||||||
Non-GAAP net earnings | $ | 102,900 | $ | 1.86 | $ | 117,700 | $ | 2.12 | |||||||||||||||
Q1 -18 forecasted shares | 55,400 | 55,400 | |||||||||||||||||||||
Note 1: The Non-GAAP adjustments are tax effected at the applicable statutory rates and the difference between the GAAP and Non-GAAP tax rates. | |||||||||||||||||||||||
Unaudited Consolidated Balance Sheet | ||||||||
(In thousands) | ||||||||
2017 | 2016 | |||||||
ASSETS | ||||||||
Cash and cash equivalents | $ | 333,768 | $ | 228,623 | ||||
Restricted cash | 119 | 5,287 | ||||||
Short-term investments | 209,434 | 189,463 | ||||||
Trade accounts receivable, net | 300,308 | 248,757 | ||||||
Inventories | 339,081 | 275,869 | ||||||
Other current assets | 53,543 | 50,770 | ||||||
Total current assets | 1,236,253 | 998,769 | ||||||
Property, plant and equipment, net | 171,782 | 174,559 | ||||||
591,047 | 588,585 | |||||||
Intangible assets, net | 366,398 | 408,004 | ||||||
Long-term investments | 10,655 | 9,858 | ||||||
Other assets | 37,883 | 32,467 | ||||||
Total assets | $ | 2,414,018 | $ | 2,212,242 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Short-term debt | $ | 2,972 | $ | 10,993 | ||||
Accounts payable | 82,518 | 69,337 | ||||||
Accrued compensation | 96,147 | 67,728 | ||||||
Income taxes payable | 25,106 | 22,794 | ||||||
Deferred revenue | 12,842 | 14,463 | ||||||
Other current liabilities | 73,945 | 51,985 | ||||||
Total current liabilities | 293,530 | 237,300 | ||||||
Long-term debt, net | 389,993 | 601,229 | ||||||
Non-current deferred taxes | 56,516 | 66,446 | ||||||
Non-current accrued compensation | 51,700 | 44,714 | ||||||
Other liabilities | 33,372 | 20,761 | ||||||
Total liabilities | 825,111 | 970,450 | ||||||
Stockholders' equity: | ||||||||
Common stock | 113 | 113 | ||||||
Additional paid-in capital | 789,644 | 777,482 | ||||||
Retained earnings | 795,698 | 494,744 | ||||||
Accumulated other comprehensive loss | 3,452 | (30,547 | ) | |||||
Total stockholders' equity | 1,588,907 | 1,241,792 | ||||||
Total liabilities and stockholders' equity | $ | 2,414,018 | $ | 2,212,242 |
News Provided by Acquire Media